Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2014

View Archived Issues

Combining GLP-1-expressing plasmids and DPP IV gene silencing for type 2 diabetes

An ultrasensitive noninvasive method for the detection of cancer biomarkers

Novel non-selective PDGFR inhibitor prevents the progression of PAH

Fullerene polyaminocaproic acid -- new potent anti-HIV drug candidate

GSK and Shionogi divulge new cephems

TP-271 shows efficacy in F. tularensis infection model

Ipsen Pharma synthesizes novel somatostatin receptor agonists

Preliminary phase I results presented for novel oligoclonal anti-EGFR antibody combination

Arena Pharmaceuticals and the University of Copenhagen prepare novel GPR119 receptor antagonists

Indian and Malaysian group present novel FabL inhibitors

Scientists at Roche disclose novel TRPA1 antagonists

Altor Bioscience to study ALT-803 in combination with BCG for bladder cancer

Aduro Biotech grants Janssen Biotech license to immunotherapies for prostate cancer

Collegium advances Hydrocodone DETERx program

Protea Biosciences and University of Southampton partner on Alzheimer's research

Shanghai Hutchison Pharmaceuticals joint venture gains rights to products in China

Arch Biopartners engages d3 Medicine to develop MetaMx for brain tumors

Memorial Sloan Kettering and Quest Diagnostics collaborate in precision medicine

Dilaforette reports phase I/II results on sevuparin in malaria

MPDL-3280A leads to rapid response in metastatic bladder cancer

Bristol-Myers Squibb designs novel IRAK-4 inhibitors

Cell Therapeutics changes name to CTI BioPharma

FDA approves Omidria for use in cataract and intraocular lens replacement procedures

Roche acquires Genia Technologies

Merrion Pharmaceuticals' GIPET technology advances with Novo Nordisk oral insulin development

FDA grants AZD-0914 fast track and QIDP designations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...